Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CLLS compared with NRXP: revenue, margins and what each company keeps, and the suppliers and customers both name
CLLS
Cellectis S.A.
Change
Mkt cap
Revenue
Revenue
NRXP
NRX Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CLLS
Cellectis S.A.
vs
NRXP
NRX Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CLLS, solid
NRXP, dashed
CLLS
Cellectis S.A.
Change
1.06
▼
−1.85%
· post 1.04
Mkt cap
$108.4M
Revenue
—
NRXP
NRX Pharmaceuticals, Inc.
Change
2.18
▼
−3.78%
· post 2.22
Closed
Nov 2 '26
Mkt cap
$98.3M
Revenue
$6,000
Q2 FY26
vs
Compare
Closed
Nov 2 '26
CLLS
Cellectis S.A.
vs
NRXP
NRX Pharmaceuticals, Inc.
1.06
▼
−1.85%
post 1.04
Price
2.18
▼
−3.78%
post 2.22
$108.4M
Mkt cap
$98.3M
—
Revenue
$6,000
Q2 FY26
Change
Change
CLLS
1.06
▼
−1.85%
vs
NRXP
2.18
▼
−3.78%
Closed
Nov 2 '26